Taking Time to Connect: A Study of Programs for Hispanic Mothers Diagnosed With Cancer and Their Children
NCT ID: NCT03951454
Last Updated: 2023-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2019-04-16
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors
NCT02521961
Stress Management Training for Latinas Receiving Chemotherapy
NCT01599520
Improving Adherence to ACS Guidelines on Nutrition and Physical Activity in Latinas With Cancer and Their Informal Caregivers
NCT04314479
Psychotherapy Intervention for Latinos With Advanced Cancer
NCT04015609
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
NCT02129049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Control group: Control subjects will receive an informational booklet published by NCI called, "Taking Time." The booklet contains information on ways to manage emotional issues, including the importance of sharing feelings about the cancer with a trusted adult confidant, learning all you can about your cancer in order to regain control and talking with medical providers, and dealing with a new self-image. This group receives one scripted telephone-delivered session guiding the mother on how to obtain the most from the booklet.
OTHER
DOUBLE
Members of the Data Collection Team at New Mexico State University (NMSU) remain "blind" on the randomization status of study participants. Randomization will be handled centrally by the team's biostatistician, Griffith, at the University of Washington. She will be responsible for centralized random assignment using block randomization \[by recruitment sites, language of program delivery, and cancer types\] and will communicate that assignment only to Palacios, Lewis and the Project Manager.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conexiones
5 telephone sessions of Conexiones, with each session delivered 2 weeks apart across a total period of 8 weeks
Conexiones
5 Conexiones telephone sessions
Taking Time
1 telephone session consisting of a scripted protocol guiding participants through the NCI's Taking Time Booklet.
Taking Time
1 Taking Time telephone session
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conexiones
5 Conexiones telephone sessions
Taking Time
1 Taking Time telephone session
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with primary, non-metastatic cancer (stage 0, I, II, or III) of any type in the past 2 years
* Has a child 5 to 17 years old living at home and who knows about their mother's cancer
* Lives in New Mexico or Texas
* Has ready access to a telephone
* Can read and write in English or Spanish
Exclusion Criteria
* Diagnosed with basal or squamous cell carcinoma
* Not able to read or write in English or Spanish
* Does not have ready access to a telephone
* Her child is not aware of the mother's cancer diagnosis
* Her child has learning challenges that would prevent him/her from engaging in a conversation with their mother
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Fred Hutchinson Cancer Center
OTHER
New Mexico State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Palacios
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Palacios, PhD
Role: PRINCIPAL_INVESTIGATOR
New Mexico State University
Frances M Lewis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington, Fred Hutchinson Cancer Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Mexico State University
Las Cruces, New Mexico, United States
Memorial Medical Center-Cancer Center
Las Cruces, New Mexico, United States
The Hospitals of Providence
El Paso, Texas, United States
University Medical Center of El Paso
El Paso, Texas, United States
Mays Cancer Center, UT Health San Antonio
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lewis FM, Casey SM, Brandt PA, Shands ME, Zahlis EH. The enhancing connections program: pilot study of a cognitive-behavioral intervention for mothers and children affected by breast cancer. Psychooncology. 2006 Jun;15(6):486-97. doi: 10.1002/pon.979.
Related Links
Access external resources that provide additional context or updates about the study.
Complementary and Alternative Medicine Questionnaire
Child Behavior Checklist for Ages 6-18
Brief COPE Inventory
COVID-19: Impact of the Pandemic and HRQoL in Cancer Patients and Survivors (IPHCPS)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17894
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.